Hopper Jonathan Mark 5
5 · Vericel Corp · Filed Feb 13, 2026
Insider Transaction Report
Form 5
Vericel CorpVCEL
Hopper Jonathan Mark
Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2025-12-31$26.27/sh+122$3,205→ 66,684 total
Footnotes (1)
- [F1]Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper|2026-02-13